Paper11699592
Protection against pulmonary infection with Klebsiella pneumoniae in mice by interferon-gamma through activation of phagocytic cells and stimulation of production of other cytokines.
Yoshida K and 6 others. J Med Microbiol, 2001. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Protection against pulmonary infection with Klebsiella pneumoniae in mice by interferon-gamma through activation of phagocytic cells and stimulation of production of other cytokines. Papers, record 11699592. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11699592
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Protection against pulmonary infection with Klebsiella pneumoniae in mice by interferon-gamma through activation of phagocytic cells and stimulation of production of other cytokines.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferon-gamma | Major topic |
| Klebsiella Infections | Major topic |
| Klebsiella pneumoniae | Major topic |
| Phagocytes | Major topic |
| Pneumonia, Bacterial | Major topic |
| Animals | |
| Bronchoalveolar Lavage Fluid | |
| Colony Count, Microbial | |
| Cytokines | |
| Disease Models, Animal | |
| Humans | |
| Kinetics | |
| Lung | |
| Mice | |
| Mice, Knockout |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41940501 | Wzi modulates immune evasion of hypervirulent Klebsiella pneumoniae in a CPS-dependent and independent manner. | Virulence | 2026 | https://conductscience.org/library/papers/41940501 | PubMed |
| 38635718 | Interferon-γ and infectious diseases: Lessons and prospects. | Science | 2024 | https://conductscience.org/library/papers/38635718 | PubMed |
| 37724373 | BATF2 enhances proinflammatory cytokine responses in macrophages and improves early host defense against pulmonary Klebsiella pneumoniae infection. | Am J Physiol Lung Cell Mol Physiol | 2023 | https://conductscience.org/library/papers/37724373 | PubMed |
| 36287114 | Autophagy, cell death, and cytokines in K. pneumoniae infection: therapeutic perspectives. | Emerg Microbes Infect | 2023 | https://conductscience.org/library/papers/36287114 | PubMed |
| 36095213 | Recurrent emergence of Klebsiella pneumoniae carbapenem resistance mediated by an inhibitory ompK36 mRNA secondary structure. | Proc Natl Acad Sci U S A | 2022 | https://conductscience.org/library/papers/36095213 | PubMed |
| 31796543 | A Porcine Ex Vivo Lung Perfusion Model To Investigate Bacterial Pathogenesis. | mBio | 2019 | https://conductscience.org/library/papers/31796543 | PubMed |
| 31595971 | Prekallikrein inhibits innate immune signaling in the lung and impairs host defense during pneumosepsis in mice. | J Pathol | 2020 | https://conductscience.org/library/papers/31595971 | PubMed |
| 31320388 | The Mycobacterium tuberculosis capsule: a cell structure with key implications in pathogenesis. | Biochem J | 2019 | https://conductscience.org/library/papers/31320388 | PubMed |
| 30452654 | Klebsiella pneumoniae infection biology: living to counteract host defences. | FEMS Microbiol Rev | 2019 | https://conductscience.org/library/papers/30452654 | PubMed |
| 29463546 | Treatment with Atorvastatin Provides Additional Benefits to Imipenem in a Model of Gram-Negative Pneumonia Induced by Klebsiella pneumoniae in Mice. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29463546 | PubMed |
| 28979250 | Evaluation of Recombinant Multi-Epitope Outer Membrane Protein-Based Klebsiella pneumoniae Subunit Vaccine in Mouse Model. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28979250 | PubMed |
| 28176791 | IL-36γ is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumonia. | Mucosal Immunol | 2017 | https://conductscience.org/library/papers/28176791 | PubMed |
| 27307579 | Klebsiella pneumoniae: Going on the Offense with a Strong Defense. | Microbiol Mol Biol Rev | 2016 | https://conductscience.org/library/papers/27307579 | PubMed |
| 26582515 | Innate Immune Signaling Activated by MDR Bacteria in the Airway. | Physiol Rev | 2016 | https://conductscience.org/library/papers/26582515 | PubMed |
| 26065469 | TIR-Domain-Containing Adaptor-Inducing Interferon-β (TRIF) Mediates Antibacterial Defense during Gram-Negative Pneumonia by Inducing Interferon-x03B3. | J Innate Immun | 2015 | https://conductscience.org/library/papers/26065469 | PubMed |
| 24442439 | Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia. | J Immunol | 2014 | https://conductscience.org/library/papers/24442439 | PubMed |
| 20412685 | Pathogenicity of Aeromonas hydrophila, Klebsiella pneumoniae, and Proteus mirabilis to brown tree frogs (Litoria ewingii). | Comp Med | 2010 | https://conductscience.org/library/papers/20412685 | PubMed |
| 17646358 | Cyclic di-GMP stimulates protective innate immunity in bacterial pneumonia. | Infect Immun | 2007 | https://conductscience.org/library/papers/17646358 | PubMed |
| 16926436 | Comparison of the host responses to wild-type and cpsB mutant Klebsiella pneumoniae infections. | Infect Immun | 2006 | https://conductscience.org/library/papers/16926436 | PubMed |
| 16299325 | Noncapsulated Klebsiella pneumoniae bearing mannose-containing O antigens is rapidly eradicated from mouse lung and triggers cytokine production by macrophages following opsonization with surfactant protein D. | Infect Immun | 2005 | https://conductscience.org/library/papers/16299325 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11699592
GET https://conductscience.org/api/papers/v1/11699592/cited_by?page=2